Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
Your AI-Powered Congress Engagement Coordinator – Connect Easily, Stay Compliant, and Follow Up Smarter
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
Our team – Tara DeBellis (Director of Strategy, US) and Leonardo Sanchez (Account Director) – is heading to Philadelphia, USA, for the biggest cross-functional gathering in North America. Held at the Pennsylvania Convention Center, this event is all about advancing pharma marketing and patient engagement. This year, every speaker is committed to delivering at least […]
See Viseven at the Future Pharma Roundtable on AI and Content Automation The Viseven team will once again join the industry leaders at the Future Pharma conference in Boston. Prasant Vijayakumar, Viseven’s Head of Content Strategy and Enablement, will participate in a roundtable on the future of pharma marketing in light of the recent advancements […]
Connect with us at Collision 2024 Viseven’s Chief Brand and Communications Officer, Yuliya Sotska, and Chief Growth Officer, Yaroslava Upatova, will be attending the Collision conference in Toronto on June 17-20, 2024. Viseven will be there for the third consecutive year, and this year Yuliya Sotska will once again be on stage as presenter and moderator. […]
Let’s connect at the Pharma 4.0: Digitalization and Transformation Conference The Viseven team will attend the Pharma 4.0: Digitalization and Transformation Conference. Anna Malivska, product manager and modular approach expert at Viseven, will be one of the conference presenters covering her topic: From Raw Data to Rich Content: Crafting compelling stories with data-driven approaches At […]
Overcome Channel Constraints in Your Content Strategy Creating, approving, and distributing campaigns is an art form that demands careful planning in various scenarios: Join us at the event, where we’ll share insights to help your content thrive across any channel, free from constraints and optimized for omnichannel success. Meet the Experts and See Real Case […]
Connect with us at 2nd Pharma Omnichannel HCP Engagement Conference The Viseven team will attend the 2nd Pharma Omnichannel HCP Engagement Conference, in Lisbon on May 23-24, 2024. Nataliya Andreychuk, co-founder and CEO of Viseven, will be among the conference speakers presenting her topic: “Exploring the Synergy Between High-Quality Content, Data, and AI in Omnichannel […]
Join Us in Unleashing Innovation at NEXT Pharma Summit 2024 The Viseven team is attending the NEXT Pharma Summit 2024 to exchange experience with the leaders of the pharma’s top companies like Bayer, Merck, Biogen, Teva, and more. The conference will take place on May 14-15 in Dubrovnik. These are busy weeks for our team […]
As the year comes to a close, we often take a moment to reflect on the past 12 months and the lessons they brought. While some look back on everything that has happened, others focus on what the future may hold. How should we move in the year to come? What does 2026 have in […]
The latest eWizard release focuses on the marketers’ pain points that don’t get enough attention in life sciences. They sit in everyday workflows, hidden in plain sight, and the status quo keeps them there. So, we decided to challenge that. This update brings improvements that make agentic AI a practical choice for compliant content creation, simplify the roll-out of modular content in life sciences, reduce the heavy dependence on creative agencies, and help […]
A marketing asset is ready for launch, but gets stuck in review. Legal raises concerns, medical edits again, and the latest version is buried in a chain of emails. The deadline is slipping, and no one’s certain what’s approved. Scenes like this are common in pharma, where compliance touches every part of content, communication, and […]
